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ABSTRACT
Background: Early detection of malignant lesions is critical key stone for the successful management of breast cancer. Conventional B-mode 
ultrasound although could not replace the histopathology which is still gold standard, plays an important role in the diagnostic pathways by using the 
Breast Imaging Reporting and Data System (BIRADS) lexicon (standardized by American College of Radiology [ACR]). Although characterization of 
solid breast masses by sonography has improved greatly since the early 1990s, specificity remains low and a large number of biopsies result in benign 
diagnosis. Strain elastography and strain ratio (SR) are recent techniques which may help in increasing the specificity of ultrasound.
Methods: The present study was a pilot study aimed to establish a correlation between B-mode ultrasound and strain elastography in differentiating 
benign and malignant breast masses and to compare the results of B- mode ultrasound and Strain Elastography with fine-needle aspiration cytology/
biopsy findings. It was a prospective study conducted in the Department of Radio-diagnosis of Rajindra Hospital, Patiala. A total of 40 patients 
who presented with the complaint of palpable breast lump were evaluated with B-Mode Ultrasonography (USG) and Strain elastography (using 
elastography score [ES] and SR).
Results: The study group (40 patients with breast lumps) comprised 38 (95%) female patients and 2 (5%) male patients. Among the group 29 
were benign and 11 were malignant. Fibroadenoma followed by fibrocystic disease was the most common benign pathologies and invasive ductal 
carcinoma followed by Ductal Carcinoma in situ was the most common malignant pathologies. Sensitivity, specificity, and diagnostic accuracy of 
B-Mode USG in diagnosing palpable breast lump are 72.7%, 86.2%, and 82.5%, respectively, while that of strain elastography in diagnosing palpable 
breast lump are 81.8%, 93.10%, and 90.0%, respectively. Using strain ratio (SR) only the sensitivity, specificity, and diagnostic accuracy was found 
to be 93.1%, 100%, and 95% better than B-Mode USG and shear elastography alone separately and combined. The mean SR for a benign mass is 
2.00±0.97 and for a malignant mass is 5.40±1.55.
Conclusion: Ultrasound elastography (using ES) has a higher sensitivity, specificity and diagnostic accuracy in differentiating benign and malignant 
breast masses then B mode USG (using BIRADS). Using SR alone has shown better sensitivity, specificity, and diagnostic accuracy but its standalone or 
in combination diagnostic application has to be followed up with further studies.
Keywords: Breast lump, Elastography, Strain ratio, Breast imaging reporting and data system.
INTRODUCTION
Palpable breast mass is one of the common complaints of all ages 
particularly during the reproductive age. Palpable breast masses 
are usually benign however efficient evaluation along with prompt 
diagnosis is necessary to rule out malignancy [1]. Breast cancer is the 
most common type of cancer among women worldwide, affecting 2.1 
million women each year. It is the leading cause of cancer related deaths 
among females today with around 15% of cancer related deaths among 
women. In India also breast cancer is the most common cancer among 
women accounting for 14% of all cancers. According to GLOBACAN 
2020; 178 361 new cases of breast cancer were registered and 90,408 
deaths were registered due to breast cancer [2].
Benign breast masses include cysts, fibroadenoma, fibro adenosis, 
fibro-adenomatous hyperplasia, intra-ductal papilloma, inflammation, 
lipomas, and benign phyllodes tumor [3].
Malignant breast masses include invasive ductal carcinoma (IDC), 
ductal carcinoma in situ (DCIS), intra-ductal papillary carcinoma, and 
mucinous carcinoma.
Several studies have described the sonographic characteristics 
commonly seen in benign lesions of the breast [4,5].
•	 Smooth and well circumscribed
•	 Thin echogenic capsule
•	 Hyperechoic, isoechoic, or mildly hypoechoic
•	 Ellipsoid shape, with the transverse diameter more than 
anteroposterior diameter
•	 Three or fewer gentle lobulations
•	 Absence of any malignant findings.
Malignant lesions are usually hypoechoic lesions with ill-defined 
borders. Typically, a malignant lesion presents as a hypoechoic lesion, 
which is “taller than broader” and has spiculated margins, posterior 
acoustic shadowing and microcalcifications [4]. Color Doppler has 
not proven to be very efficacious in improving the specificity of 
ultrasonography (USG); however, in certain situations it may help to 
resolve the issue, particularly when there is significant vascularity 
present within highly cellular types of malignancies [6].
The downside of USG is an increased false positive rate and lower 
positive predictive value (PPV). To obtain an acceptable specificity 
various eight characteristics of the lesion must be evaluated 
according to the breast imaging reporting and data system (BIRADS) 
criteria defined by American College of Radiology (ACR). However, 
BIRADS criteria generate significant number of false positive 
results [7].
© 2021 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/4.0/) DOI: http://dx.doi.org/10.22159/ajpcr.2021v14i7.42378. Journal homepage: https://innovareacademics.in/journals/index.php/ajpcr
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Ultrasound elastography aims to overcome the limitations of ultrasound 
and to obtain an accurate characterization of breast lesions. It depicts 
the stiffness of tissues [8]. Elastography techniques are of two types; 
first is dynamic elastography which included shear wave and acoustic 
radiation force pulse while the second is static elastography which 
includes strain elastography [8].
Strain elastography allows evaluation of the elasticity score (ES) as a 
qualitative parameter of stiffness and the strain ratio (SR) as a semi-
quantitative method for numerically evaluating how many times stiffer 
a target mass is compared to the subcutaneous fat [9].
The elastography score (ES) will be interpreted according to the 5-point 
TSUKUBA Scoring method proposed by Itoh et al. in 2006 [8].
A score of 1–3 indicates toward a probably benign mass while a score 
of 4 and 5 should raise a suspicious of malignancy. This system is said 
to have a sensitivity of 87%, specificity of 90%, and diagnostic accuracy 
of 88%.
SR is defined as the fat to mass SR and will be automatically calculated 
by the embedded software program in the ultrasound unit. The higher 
the strain-ratio the higher the likelihood of malignancy.
SR = Mean strain of fat area/mean strain in lesion of interest [10].
Although characterization of solid breast masses by sonography has 
improved greatly since the early 1990s, specificity remains low and 
a large number of biopsies (>50%) result in benign diagnosis. Strain 
elastography is a recent technique which may help in increasing the 
specificity of ultrasound and hence reducing the biopsy load. The study 
aimed at assessing the diagnostic role of strain elastography and its 
parameters.
Aims and Objectives
The objectives are as follows:
1. Assess the diagnostic role of strain elastography and SR
2. Compare the results of B-mode ultrasound and strain elastography 
with fine-needle aspiration cytology (FNAC)/biopsy findings.
METHODS
This prospective observational analytic pilot study was carried out in 
the Department of Radio-Diagnosis, Rajindra Hospital, Patiala. The study 
included 40 consenting patients of 18 years and above among the ones 
presenting with breast lump in the outpatient department or admitted 
in the wards in Rajindra Hospital, Patiala, who were referred to the 
Department of Radiodiagnosis for investigation and were after enrollment 
were latter followed up to histopathology of the lump. The patients who 
are below 18 years, already diagnosed and treated for breast lump, or had 
physiological or post-traumatic or post-infective breast swelling and who 
did not give consent were excluded from the study.
Sample size was calculated using formula (Z1-α/22 p (1-p))/d2 where Z1-α/2 
is Standard normal variate 1.96, d is absolute error which is taken 10% 
in this study and p is expected proportion in population which in this 
study is expected population getting histopathology out of population 
who have lump in breast which was taken as 10% based on previous 
records who fulfill the inclusion criteria. The calculated sample size was 
35 and keeping 10% as expected loss during study and follow-up the 
sample size was rounded up to 40 patients.
Instrumentation, Patient Positioning, and Breast Survey 
Techniques
B-Mode ultrasound and Strain Elastography were performed using 
PHILIPS EPIQ5 S.NO. U5318C0517 machine using high frequency L12-
5 transducer. Each lesion was assessed with the BIRADS).
Sonographic parameters including size, shape, margin, orientation, 
posterior acoustic features, calcifications, axillary lymphadenopathy, 
and internal vascularity. The BIRADS categories were assigned 
according to the BIRADS US lexicon, 5th edition, by the ACR in 2013.
BIRADS staging Interpretation
BIRADS 1 Normal
BIRADS 2 Definitely benign
BIRADS 3 Probably benign
BIRADS 4 Probably malignant
BIRADS 5 Definitely malignant
BIRADS 6 Known malignancy
BIRADS: Breast Imaging Reporting and Data System
Doppler characteristics such as absence of flow, distribution, and 
pattern of vessels in the mass lesion were also noted. The location of the 
lesion was labeled according to o’clock position and distance from the 
nipple. The anterior, posterior, and lateral dimensions were recorded 
for the reference of AP/L ratio.
Then using the same probe, strain elastography was performed while 
keeping the probe perpendicular to the skin during compression. The 
region of interest (ROI) was set for elastography acquisition; superior 
margin includes subcutaneous fat; inferior margin include pectoral 
muscle; and lateral margin should have 10 mm distance from the 
lesion. The target lesion was compressed vertically by applying light 
pressure. High levels of pressure were avoided because in such cases 
the association between pressure and strain is no longer proportional 
and false results may be found.
The ES and SR were measured on coupled B-Mode and Elastography 
images. Inside the field of view box, we positioned the first ROI in the 
lateral subcutaneous fat tissue at the same depth as the target lesion 
and with the second ROI we outlined the entire lesion.
The ES was interpreted according to the 5-point TSUKUBA Scoring 
method proposed by Itoh et al. in 2006 [8] [Figure 1].
TSUKUBA scoring system [8]
Score 1 – even strain for entire hypo-echoic lesion (i.e. the entire lesion 
is evenly shaded in blue).
Score 2 – strain in most of the hypo-echoic lesion (i.e. the hypo-echoic 
lesion has the mosaic pattern of blue and green).
Score 3 – strain at the periphery of the hypo-echoic lesion (i.e. peripheral 
part is blue and the central part is red)
Score 4 – no strain in the entire hypo-echoic lesion (i.e. the entire lesion 
is red but the surrounding area is not included).
Score 5 – no strain in the entire hypo-echoic lesion or in the surrounding 
area (i.e. both the entire lesion and its surrounding area are red).
A ES of 1 to 3 indicates toward a probably Benign mass while a score of 
4 and 5 should raise a suspicious of malignancy.
Data collection and analysis
Data collection and analysis was done using Microsoft Excel, Epi info 
version 7.2.4.0 (CDC Atlanta) and Medcalc Statistical Software version [12]. 
Most of the values are described in percentages and means, while other 
analytic tests included Shapiro–Wilk Test (For normality of data, Chi-
square test, Fisher’s Exact, Mann–Whitney test, ROC analysis, and Kendell 
Rank correlation coefficient test. Diagnostic utility parameters such as 
sensitivity, specificity, Youden index (50% benchmark for diagnostic utility), 
PPV, negative predictive value (NPV), and Kappa were also calculated.
RESULTS
The final pathological diagnosis showed the benign masses to be 72.5 
% (29 cases) and malignant breast lumps to be 37.5% (11 patients) of 
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the study population. The mean age of the cases was 37.28 years with 
a standard deviation of 13.21. The malignant masses were present 
significantly higher in older age groups than the benign as shown in 
Table 1a and b.
Histopathology of lump masses
The histopathological report (Table 2) showed that fibroadenoma 
followed by fibrocystic disease was the most common benign pathology 
and IDC followed by ductal carcinoma in situ was the most common 
malignant pathology in patients presenting with palpable breast lumps.
BIRADS Ultrasound and other descriptors
Antiparallel placement (taller than wider), Spiculation-micro lobulation, 
Posterior acoustic shadow, presence of microcalcifications, internal 
vascularity, and axillary lymphadenopathy are the characteristics which 
were significantly higher present in malignant than benign masses. No 
significant difference was found in hypoechoic dominance in the two 
groups (Table 3a).
In this study, the descriptors antiparallel placement, spiculations, 
microcalcifications, and Posterior acoustic shadow have shown more 
than 95% specificity, more than 80% PPV and fall in Rule in category 
which means that if present than it is a malignant lesion, while 
hypoechoic dominance has a high sensitivity, high NPV and falls in 
rule out category which means that if not present than it rules out 
malignancy. But as spiculations, microcalcifications, posterior acoustic 
shadow, and hypoechoic dominance have a Youden index less than 
50%; hence, the parameter does not meet empirical benchmarks for 
being used for diagnostic purposes. Internal vascularity and axillary 
lymphadenopathy have near 90% NPV and a good PPV may strongly 
indicate toward malignancy [Table 3b].
Diagnostic cutoff values and diagnostic utility parameters of 
procedures
The cutoff values and diagnostic utility parameters of BIRADS, strain 
elastography, and SR were calculated for the study [Tables 4(a-c) and 5], 
[Figure 2]. 
In our study, the cutoff values (maximum Sensitivity +Specificity) are 
BIRADS III, ES of 3 and SR of 3. These cutoffs are similar to the cutoff 
values in the standards literature and scoring system for BIRADS and 
strain elastography.
In the study, the diagnostic utility indicators are summarized in 
Table 6 show that the indicators of strain elastography are better than 
that of BIRADS, while those of SR are better than BIRADS and strain 
elastography.
Correlation of conventional ultrasound, strain elastography, and SR 
with histopathology
•	 Conventional ultrasound (BIRADS) and Histopathology: With the 
cutoff value of BIRADS III, out of 29 benign lesions 25 were diagnosed 
as benign while four lesions showed BIRADS IV or more. While eight 
masses with BIRADS IV and V were diagnosed, as malignant out of 11 
Table 1: Distribution of study population according to the age
(a) Mean
Age Obs Mean Std Dev Min 25% Median 75% Max Mode p-value
Study population 40 37.28 13.21 20 28 32 49.5 70 30
Benign 29 31.83 8.98 20 27 30 32 63 30 <0.001*
Malignant 11 51.64 11.91 33 38 52 60 70 60
*Mann–Whitney test for two independent samples (z=4.128)
(b) Age groups
Age groups Benign* Malignant* Total Test p-value
15–30 years 13 (100%, 44.83%) 0 13 Fischer exact 0.0002 
30–45 years 13 (81.25%, 44.83%) 3 (18.75%, 27.27%) 16
45–60 years 2 (25%, 6.9%) 6 (75%, 54.55%) 8
60–75 years 1 (33.33%, 3.45%) 2 (66.67%, 18,18%) 3
Total 29 11 40
*In () the first % is of respective age group while second % is of respective pathology category
Table 2: Frequency of distribution of breast lump according to the histopathological diagnosis
Histopathology Frequency Percent Exact 95% LCL Exact 95% UCL
Benign 29 72.50 56.11 85.40
Fibroadenoma 17 42.50 27.04 59.11
Fibroadenoma with atypia 1 2.50 0.06 13.16
Fibrocystic disease 2 5.00 0.61 16.92
Intraductal Papilloma 1 2.50 0.06 13.16
Ductal Ectasias 3 7.50 1.57 20.39
Lipoma 1 2.50 0.06 13.16
Nodular gynecomastia 1 2.50 0.06 13.16
Phyllodes 1 2.50 0.06 13.16
Idiopathic Granulomatous mastitis 1 2.50 0.06 13.16
Sclerosing adenitis 1 2.50 0.06 13.16
Malignant 11 27.50 14.60 43.89
IDC 6 15.00 5.71 29.84
Ductal carcinoma in situ 2 5.00 0.61 16.92
Medullary carcinoma 2 5.00 0.61 16.92
Malignant lymph node 1 2.50 0.06 13.16
Total 40 100.00
IDC: Invasive ductal carcinoma
156
Asian J Pharm Clin Res, Vol 14, Issue 7, 2021, 153-163
 Gupta et al.
proven malignant cases. Three malignant cases had been categorized 
as probably benign with ≤BIRADS III. This was statistically significant 
(Fisher exact, p<0001)
•	 Correlation of Elastography using ES and Histopathology: 27 of the 29 
benign masses had an ES 3 or less which was the cutoff. Two cases with 
ES 4 were found out to be benign. On the other hand, two with a score of 
3 were malignant besides other 9 who had a score of 4 (5 masses) and 
5 (4masses). This was statistically significant (Fisher exact, p<0001)
•	 Correlation of SR and Histopathology: The mean SR of the study 
population and histopathology groups of benign and malignant is 
shown in Table 7 [Figure 3].
From Table 4c, the cutoff value of SR is 3. Hence, at this level, 27 of the 
29 diagnosed benign cases had value less than or equal to 3 while two of 
them had SR >3. All the diagnosed malignant cases had an SR value>3. 
This was statistically significant (Fisher exact, p<0.001).
•	 Correlation of conventional ultrasound (BIRADS) and elastography 
using ES: Out of the 29 benign cases 25 had both BIRADS III or less 
and ES of 3 or less. While among the 4 benign cases who had BIRADS 
more than 3, two cases had an ES <3. On the other had among the 
histopathologically diagnosed malignant lesions, seven both had 
>BIRADS III and ES >3; two cases with ≤BIRADS III had an ES>3, 
one case had >BIRAD III but ES<3; and one case had both BIRADS 
III and ES 3. Both the finding in benign and malignant groups were 
statistically significant (Kendell’s rank correlation test; p<0.001)
•	 Correlation of conventional ultrasound (BIRADS) and SR: 25 cases 
of benign pathology had both ≤BIRAD III and SR≤3, 2 cases had > 
BIRAD III but SR≤3 and remaining 2 cases had both >BIRAD III and 
SR>3. In the malignant group, all cases had an SR>3 but 3 cases 
had BIRAD III. (Statistically significant for benign, Fisher exact, 
p<0.05)
•	 Correlation of elastography using ES and SR: 27 cases of benign 
pathology had both ES≤3 and SR≤3, and 2 cases had both ES>3 and 
SR>3. In the malignant group all cases had an SR>3 but 2 cases had 
ES≤3. (Statistically significant for benign, Fisher exact, p<0.05).
Discordant cases from correlation observation
The cases who had discordant values than for benign and malignant 
diagnostic modalities are summarized in Table 8a and b.
From Table 8a, if ES or SR was combined with BIRADS, 2 of the benign 
lesions would have been labeled as benign before histopathology. This 
in practical terms means a reduction of 25% in BIRADS IV (total eight 
patients) FNAC/Biopsies in this study presuming that all BIRAD Cases 
above BIRAD III are subjected to FNAC/Biopsy.
Table 4b: Diagnostic cutoff values and diagnostic utility 
parameters of strain elastography using ES
ES→ ES 2 ES 3 ES 4 ES 5
Sensitivity 72.4% 93.1% 100.0% 100.0%
Specificity 100.0% 81.8% 36.4% 0.0%
PPV 100.0% 93.1% 80.6% 72.5%
Negative predictive value 57.9% 81.8% 100.0%
Sensitivity +Specificity 172.4% 174.9% 136.4% 100.0%
Accuracy 80.0% 90.0% 82.5% 72.5%
Youden Index 72.4% 74.9% 36.4% 0.0%
Kappa 59.1% 74.9% 45.3% 0.0%
ES: Elastography score, PPV: Positive predictive value
Table 4a: Diagnostic cutoff values and diagnostic utility 
parameters of BIRADS








Sensitivity 65.5% 86.2% 100.0% 100.0%
Specificity 90.9% 72.7% 36.4% 0.0%
PPV 95.0% 89.3% 80.6% 72.5%
Negative predictive value 50.0% 66.7% 100.0%
Sensitivity + Specificity 156.4% 158.9% 136.4% 100.0%
Accuracy 72.5% 82.5% 82.5% 72.5%
Youden index 56.4% 58.9% 36.4% 0.0%
Kappa 45.0% 57.3% 45.3% 0.0%
BIRADS: Breast imaging reporting and data system, PPV: Positive predictive value
Table 4c: Diagnostic cutoff values and diagnostic utility parameters of SR
Strain 
Ratio→
SR 1 SR 2 SR 3 SR 4 SR 5 SR 6
Sensitivity 17.2% 55.2% 93.1% 96.6% 96.6% 100.0%
Specificity 100.0% 100.0% 100.0% 72.7% 63.6% 27.3%




31.4% 45.8% 84.6% 88.9% 87.5% 100.0%
Sensitivity 
+Specificity 
117.2% 155.2% 193.1% 169.3% 160.2% 127.3%
Accuracy 40.0% 67.5% 95.0% 90.0% 87.5% 80.0%
Youden index 17.2% 55.2% 93.1% 69.3% 60.2% 27.3%
Kappa 10.3% 40.4% 88.1% 73.4% 65.8% 35.2%
SR: Strain ratio, PPV: Positive predictive value
Table 3a: Frequency of ultrasound and other descriptors in benign and malignant groups
 Ultrasound and other 
descriptors
Benign Malignant p-value
No. Percent Exact 95% LCL Exact 95% UCL No. Percent Exact 95% LCL Exact 95% UCL
Antiparallel placement 0 0.00 0.00 0.00 6 54.55 23.38 83.25 <0.0001
Spiculations 1 3.45 0.09 17.76 5 45.45 16.75 76.62 <0.0001
Microcalcifications 0 0.00 0.00 0.00 4 36.36 10.93 69.21 <0.001
Hypoechoic dominance 21 72.41 52.76 87.27 10 90.91 58.72 99.77 0.211
Posterior acoustic shadow 0 0.00 0.00 0.00 4 36.36 10.93 69.21 <0.001
Internal vascularity 5 17.24 5.85 35.77 8 72.73 39.03 93.98 <0.001
Axillary lymphadenopathy 3 10.34 2.19 27.35 8 72.73 39.03 93.98 <0.0001
Table 3b: Diagnostic utility parameters of ultrasound and other descriptors
Ultrasound and other 
descriptors




Antiparallel placement 54.55 100.00 54.55 True False 100.00 85.29 87.50
Spiculations 45.45 96.55 42.01 True False 83.33 82.35 82.50
Microcalcifications 36.36 100.00 36.36 True False 100.00 80.56 82.50
Hypoechoic dominance 90.91 27.59 18.50 False True 32.26 88.89 45.00
Posterior acoustic shadow 36.36 100.00 36.36 True False 100.00 80.56 82.50
Internal vascularity 72.73 82.76 55.49 False False 61.54 88.89 80.00
Axillary lymphadenopathy 72.73 89.66 62.38 False False 72.73 89.66 85.00
PPV: Positive predictive value
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Similarly in Table 8b, three malignant lesions would have been missed 
if BIRAD III were not subjected to biopsy it means that approx. 27% of 
would have been missed. But if combined with ES two cases of three 
would have been biopsied resulting <10% of cases would remain 
undiagnosed; but with SR all three cases would have been biopsied in 
this study.
One malignant case had ES≤3 with BIRADS IV; this was again clarified 
with SR and the patient lump would have been biopsied.
From Table 9, its evident that using BIRADS or ES in combination with 
SR is better than that of BIRADS and ES combined. And using SR in 
BIRADS or ES where SR and BIRADS/ES are in discordant in labeling 
benign/malignant lesion is better than combining the two.
Taking the above discordant cases as in Table 8a using SR, 2 of the 
BIRADS labeled malignant would have been labeled as benign before 
histopathology. While in Table 8b, all the discordant cases whether with 
BIRADS or ES would have been labeled malignant.
DISCUSSION
Breast cancer has a high mortality rate due to the higher stages of 
malignancy at the time of diagnosis. Hence, more accurate modalities 
for better diagnosis are required to be used in the primary stages. In 
the present study, we used SE additionally to conventional B-mode 
ultrasound imaging. Two different features of SE were included in our 
results ES and SR.
Lesions graded as BIRADS 3 are probably benign and short term 
follow-up is recommended. Nevertheless, malignancy is eventually 
diagnosed in about 3% of these lesions resulting in delayed diagnosis of 
cancer in a considerable number of patients [13].
In our study, the malignant masses were present in older age groups and 
with higher mean age than the benign. This age statistics is comparable 
with the present trend in the incidence of breast cancer among Indian 
women which is in increasing numbers of female from 25 to 40 years of 
age as stated by Sandhu et al. [14] and Somdatta et al. [15]
The present study revealed that the benign masses (72.5%) are more 
frequent than malignant ones (27.5%). Our study (Table 2) correlates 
with studies of Nigam et al. [16] and Phurailatpam et al. [17] which 
also show fibroadenoma followed by fibrocystic disease as the most 
common benign pathology and IDC followed by DCIS as the most 
common malignant pathology in patients presenting with palpable 
breast lumps.
The ultrasound descriptors in study, antiparallel placement, 
Spiculation-microlobulation, Posterior acoustic shadow, presence of 
microcalcifications, internal vascularity, and axillary lymphadenopathy 
are that the characteristics were found significantly in the 
malignant breast masses but due to low Youden index spiculations, 
microcalcifications and posterior acoustic shadow cannot be used for 
diagnostic purposes. Stavros et al.,[4] Constatini et al., [18] and Hong 
et al. [19] documented the characterization of solid breast masses and 
found these present in the malignant breast masses with high PPV.
We found that using BIRADS (with a sensitivity of 86.2% and specificity 
of 72.7%) out of 40 cases, 33 (82.5%) cases were diagnosed correctly 
as per histopathological grouping (benign and malignant) which 
increased to 36 (90%) cases using ES in strain elastography (with a 
sensitivity of 93.1% and specificity of 81.8%) and further to 38 (95%) 
cases using SR in strain elastography (with a sensitivity of 93.1% and 
specificity of 100%).
The diagnostic accuracy and AUC increased from 82.5%, 0.870 with 
BIRADS to 90%, 0.953 with ES and 95%, 0.980 with SR respectively. 
SR has also been found better than ES and Conventional by Parajuly 
et al. and Thomas et al. Parajuly et al. reported a higher AUC with SR 
(0.96) than ES (0.90) and conventional ultrasound (0.88) while Thomas 
et al. had documented a sensitivity and specificity of 96% and 56% for 
B-mode scanning, 81% and 89% for elastography, and 90% and 89% 
for SR.
We found that combined use of B-mode USG with ES score or SR is 
more effective in differentiating malignant and benign lesions than 
sonography alone. Different combinations were tried using BIRADS, 
strain elastography using ES and SR (Table 9). The AUC increased 
from 0.870 using BIRADS alone to 0.886 while using BIRADS and ES 
combined and to 0.920 if ES was used in discordant cases only. On the 
other hand, AUC increased from 0.870 using BIRADS alone to 0.931 
while using BIRADS and SR combined and to 0.961 if SR was used in 
discordant cases only. SR has shown better parameters than ES in this 
study.
Similar increase in AUC from BIRADS to combining it with ES was seen 
by Hao et al. [20] (0.73–0.87) and Yeo et al. (0.65–0.86) [21].
Table 7: Descriptive statistics of SR of study population and histopathology groups
Parameter 
Assessed
Obs Total Mean Var Std Dev Min 25% Median 75% Max Mode
Study population 40 117.34 2.93 3.67 1.91 0.56 1.78 2.21 3.85 8.1 2.2
Benign* 29 57.9 2.00 0.94 0.97 0.56 1.3 2 2.24 5.4 2.2
Malignant* 11 59.44 5.40 2.41 1.55 3.5 3.9 5.2 6.7 8.1 3.5
*Significant difference, Mann–Whitney Test for Two Independent Samples (z=4.6208; p<0.0001). SR: Strain ratio
Table 6: Summary of diagnostic utility indicators
Diagnostic Utility 
Indicators
BIRADS Strain elastography 
using ES
SR
Sensitivity 86.2% 93.1% 93.1%
Specificity 72.7% 81.8% 100.0%
PPV 89.3% 93.1% 100.0%
Negative predictive value 66.7% 81.8% 84.6%
Sensitivity + Specificity 158.9% 174.9% 193.1%
Accuracy 82.5% 90.0% 95.0%
Youden index 58.9% 74.9% 93.1%
Kappa 57.3% 74.9% 88.1%
AUC 0.870 0.953 0.980
SR: Strain ratio, BIRADS: Breast imaging reporting and data system, PPV: 
Positive predictive value
Table 5: ROC analysis of BIRADS, strain elastography using ES 
and SR
Feature BIRADS Strain elastography 
using ES
Strain ratio
Area under the 
ROC curve (AUC)
0.870 0.953 0.980








SR: Strain ratio, BIRADS: Breast imaging reporting and data system
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The cutoff values of the three diagnostic utilities in our study were 
BIRAD III for conventional ultrasound, ES of 3 for strain elastography 
and SR 3 for SR in strain elastography. The cutoff of BIRADS and ES 
was documented to be similar to that of BIRADS guidelines and scoring 
system, respectively [8].
SR cutoff was documented 1.90 by Ranjkesh et al., [22] 2.54 by Thomas 
et al., [9] 3.1 by Ozel et al., [23] 3.5 by Bojanic et al., [24] 3.54 by Parajuly 
et al., [25] 3.65 by Gheonea et al., [26] 4.15 by Li et al., [27] 4.8 by Barr 
et al., [28] and 5.6 by Alhabshi et al. [29]
The variation in the cutoff values among these studies 1.90–5.6 can be 
a result of pre-compression, especially by a radiologist with inadequate 
clinical experience [24,30]. Pre-compression increases the stiffness of 
all tissues hence changing the strain value of fat. This stiffness variation 
in fat tissue is more prominent than those in normal breast tissue and 
masses; thus, with pre-compression, the SR will decrease [24]. The 
other reason that could explain the SR results obtained in our and other 
studies is ROI inconsistency [24] and movement of patient [9] during 
procedure besides this variation in SR can be attributed to the different 
equipment used [22].
Another aspect of the study was the type of lesions that were discordant 
on different diagnostic utilities.
In our study, the benign lesion which was diagnosed as malignant, that 
is, false-positive lesions is IGM, Sclerosing adenitis, a fibroadenoma and 
phyllodes. IGM and fibroadenoma appeared soft on Elastography both 
with ES and SR. Sclerosing adenitis and phyllodes were false positive in 
all diagnostic utilities used.
Arslan et al. [31] reported that IGM was categorized BIRADS III on 
B-Mode USG based on its characteristics of irregular heterogeneously 
hypoechoic mass with tubular extensions. However, IGM appeared soft 
on SE with elasticity score of 2 and lower SR.
Chen et al. [32] reported that sclerosing adenitis is a benign 
proliferative disease which exhibits USG characteristics of 
malignancy such as calcifications, indistinct margins, PAS, and 
hypervascularity which contributed to the overestimation of 
this lesion on USG. Moukhtar et al. [3] reported that B-Mode USG 
revealed BIRADS score IV and Elasticity score 3 for Sclerosing 
adenitis.
Li et al. [33] reported approximately 25% of phyllodes masses reporting 
an ES score more than 3. Similar false-positive results with phyllodes 
were reported by Khanduri et al. [34]
Li et al. [33] has documented 5% of fibroadenoma to have an ES more 
than 3 as compared to 5.8% reported in our study.
In our study, one case of Infiltrating ductal carcinoma – Adenoid cystic 
type (IDC-ACT) which was reported as BIRADS IV on B-Mode USG, 
displayed ES 3 and higher SR of 3.9.
Huang et al.,[35] Ichikawa et al., [36] and Tang et al. [37] stated that 
adenoid cystic carcinoma is a rare breast tumor which can mimic benign 
lesion on ultrasound. Elastography may be helpful in differentiating 
between malignancy and benignity.
In our study, we reported one case of adenoid cystic tumor which 
showed well defined margins with minimal internal vascularity, no 
calcification or no PAS and was reported as BIRADS III on B-Mode USG. 
On elastography it displayed ES 3 and higher SR of 3.9.
In our study, two cases of medullary carcinoma were discordant 
among diagnostic utilities. Jin et al. [38] stated that 60% of medullary 
carcinoma mimicked a benign appearance on B-mode USG and 
exhibited high stiffness on Strain elastography. Meyer et al. [39] 
stated that medullary carcinoma of breast appears as well defined, 
non-calcified mass with no PAS on B-mode ultrasound and mimics as 
benign mass.
One malignant lymph node was present among discordant 
masses (Table 8b). Choi et al. [40] reported that metastatic 
lymphadenopathy can be misdiagnosed as reactive adenitis on 
B-Mode USG. Strain elastography combined with B-mode USG 
increased the sensitivity of axillary lymph node metastasis 
Table 8b: Different diagnostic values of discordant malignant 
cases
Cases Histopathology BIRADS ES SR Antiparallel 
placement
1 Medullary Carcinoma III 4 4.3 No
2 Medullary Carcinoma III 3 3.5 Yes
3 Malignant Lymph Node III 4 3.8 No
4 IDC IV 3 3.69 No
BIRADS: Breast imaging reporting and data system, IDC: Invasive ductal 
carcinoma
Table 8a: Different diagnostic values of discordant benign cases
Cases Histopathology BIRADS ES SR Antiparallel 
placement
1 Phyllodes IV 4 5.34 No
2 Sclerosing adenitis IV 4 3.5 No
3 Fibroadenoma IV 3 2 No
4 Idiopathic 
Granulomatous mastitis
IV 3 2.65 No
BIRADS: Breast imaging reporting and data system















Sensitivity 86.21% 86.21% 93.10% 93.10% 93.10% 93.10%
Specificity 100.00% 90.91% 100.00% 100.00% 90.91% 100.00%
PPV 100.00% 96.15% 100.00% 100.00% 96.43% 100.00%
Negative predictive value 73.33% 71.43% 84.62% 84.62% 83.33% 84.62%
Sensitivity +Specificity 1.862 1.771 1.931 1.931 1.840 1.931
Accuracy 0.900 0.875 0.950 0.950 0.925 0.950
Youden index 0.862 0.771 0.931 0.931 0.840 0.931
Kappa 0.775 0.711 0.881 0.881 0.817 0.881
AUC 0.931 0.886 0.966 0.966 0.920 0.966
*Combination made by combining the common and either diagnosed histopathological groups by individual modalities. **Combination made by combining common 
+ ones with difference the superior finding prevailing, that is, SR prevails over ES and BIRADS while ES prevails over BIRADS, SR: Strain ratio, BIRADS: Breast imaging 
reporting and data system, PPV: Positive predictive value
Figure 2: ROC of breast imaging reporting and data system, strain elastography using ES and strain ratio
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Figure 1: (a-b): 5-point TSUKUBA Scoring method*. *Images present general appearance of lesions for elasticity scores of (a) 1, (b) 2, (c) 3, 
(d) 4, and (e) 5. Black circle indicates outline of hypoechoic lesion (i.e., border between lesion and surrounding breast tissue) on B-mode 
images [8]. **Breast elastography images are classified in five categories (Tsukuba elasticity scores 1–5) based on strain image patterns 
superimposed on B-mode images. Lesions scored 1 or 2 are considered benign, lesions scored 3 are considered to be probably benign and 
lesions scored 4 or 5 are considered malignant [11]
b
a
Figure 6: Case 3: Adenoid cystic carcinoma
Figure 5: Case 2: Medullary carcinoma
Figure 3: Boxplot graphs demonstrating a difference in elastography strain ratio for different breast lesions. Whiskers and lines delineate 
95% confidence intervals
Figure 4: Case 1: Fibroadenoma
Table 10: Disagreement Pattern and proposed diagnostic utility 
addition
BIRADS Discordant masses ES SR
II No disagreement
III Yes Add Add
IV Yes Add Add
V No disagreement
SR; Strain ratio, BIRADS: Breast imaging reporting and data system, ES: 
Elastography score
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detection. Sonographic elastography is helpful in differentiating 
reactive and metastatic axillary lymph nodes.
Ozel et al. [23] calculated the mean SR for benign lesions was as 2.1±1.6 
(mean±standard deviation) and malignant lesions was 4.6±2.6 while 
Bojanic et al. [24] documented that mean SR for the benign lesions was 
2.3 (1.5-3.1) and for malignant lesions was 4.9 (3.8-6.1). Other studies 
Figure 9: Case: 6: Nodular gynecomastia
Figure 8: Case: 5: Fibroadenoma with atypia
Figure 7: Case 4: Invasive ductal carcinoma
161
Asian J Pharm Clin Res, Vol 14, Issue 7, 2021, 153-163
 Gupta et al.
had shown varied SR for malignant lesions as 3.02±1.3 in Lee et al. [6] 
and 7.9±5.8 Mu et al. [41]
Strain elastography as an imaging modality requires external 
compression, applied manually, hence is operator dependent, which 
influences its reproducibility. Yerli et al. [42] in a study concluded 
that after evaluation of lesions with the Tsukuba elasticity scoring 
system, additional evaluation of the SR increased calculation time and 
did not contribute significantly to the differentiation between benign 
and malignant lesions. Menezes et al. [30] assessed four elastography 
criteria (ES, SR, distance ratio, and area ratio) and reported that all four 
were able to differentiate benign and malignant lesions, but the ES was 
the most accurate. This is in agreement with our results that either 
ES or SR was able to differentiate benign and malignant lesions with 
statistical significance.
In our study, the disagreement/discordant masses fell in two categories 
of BIRADS, that is, BIRAD III and IV. If we add sonoelastography for 
these two categories the sensitivity and specificity show significant 
improvement; more if we use SR than ES [Table 10].
CONCLUSION
Ultrasound elastography was found to have high sensitivity, specificity, 
and diagnostic accuracy in differentiating benign and malignant breast 
masses than conventional B mode ultrasound. SR has shown potential 
to be used as a compliment to BIRADS better than ES. Using SR alone 
has shown better sensitivity, specificity, and diagnostic accuracy but its 
standalone or in combination diagnostic application has to be followed 
up with further studies.
Some case discussions of study
Case 1
24 years unmarried pre-menopausal female with painless lump 
left breast in the retro areolar region. Sonoelastography and 
B-mode US on split screen mode. B-mode USG revealed well defined 
smoothly marginated oval shaped hypodense lesion with no internal 
calcifications, no PAS, and no internal vascularity on color Doppler. No 
axillary lymphadenopathy was seen. BIRADS II. The strain elastography 
revealed the entire hypoechoic mass coded blue and green (Elasticity 
score 2 and SR of 2.6). This mass was considered as benign. 
Histopathological results proved a case of fibroadenoma [Figure 4].
Case 2
50 years married postmenopausal female presented with painless 
lump left breast in the Upper inner quadrant. Sonoelastography and 
B-mode US on split screen mode. B-Mode USG revealed a relatively 
well defined oval shaped hypodense mass in the upper inner quadrant 
with no internal calcifications or PAS. On CDFI internal vascularity is 
present. Axillary lymphadenopathy was seen. BIRADS III (probably 
benign). Elastography findings revealed mix pattern of blue green and 
red. The central part is harder than the periphery. The surrounding 
tissue displays blue color. Elasticity score 3 and SR- 3.5. This mass was 
considered as probably benign on B-Mode USG and equivocal on strain 
elastography. The histopathological results proved a case of Medullary 
Carcinoma [Figure 5].
Case 3
37 years old married premenopausal female with painless lump left 
breast in the retro areolar region. B-Mode USG revealed relatively 
well defined oval shaped hypodense mass in the retro areolar with no 
internal calcifications or PAS. On CDFI no internal vascularity is present. 
Axillary lymphadenopathy was seen. BIRADS III, that is, probably 
benign. Elastography revealed that the center of the mass is hard, that 
is, red in the center and soft at the periphery, that is, blue. Surrounding 
tissue also displays normal strain. Elasticity score 3 and SR- 3.69 
Histopathology proved the mass was infiltrating ductal carcinoma – 
adenoid cystic type (IDC-ACT) [Figure 6].
162
Asian J Pharm Clin Res, Vol 14, Issue 7, 2021, 153-163
 Gupta et al.
Case 4
60 years married postmenopausal female presented with painless 
lump left breast in the retro areolar region. USG revealed Ill well defined 
hypodense, taller than wider mass with spiculated margins showing 
internal microcalcifications and PAS in the retro areolar region. On 
CDFI, internal vascularity was present. Axillary lymphadenopathy was 
seen. BIRADS V (definitely malignant). Elastography findings revealed 
the entire mass was hard, that is, the entire mass is red with infiltration 
of the surrounding tissue at places – Elasticity score 5 and SR- 7.7. 
Histopathology proved the mass as infiltrating ductal carcinoma (IDC) 
[Figure 7].
Case 5
63 years married postmenopausal female with painless lump right 
breast in the UOQ.USG revealed well defined, lobulated, oval shaped 
hypodense mass with lobulated margins showing no internal 
microcalcifications and PAS in the right upper outer quadrant. On CDFI, 
internal vascularity was present. Axillary lymphadenopathy was not 
seen. BIRADS IV, that is, probably malignant. Elastography revealed 
mixed strain of blue green and red. Elasticity score 3 and SR- 1.9. The 
mass was considered benign on elastography. Histopathology proved 
the mass as fibroadenoma with atypia [Figure 8].
Case 6
50 years male presented with lump in the retro areolar regions revealed 
Ill-defined hypoechoic mass with no internal calcifications or PAS in 
the left retro areolar region. On CDFI, internal vascularity was absent. 
Axillary lymphadenopathy was not seen. BIRADS III, that is, probably 
benign. Elastography revealed the entire lesion is soft and displays 
blue color – Elasticity score 2 and SR- 2.02. It was considered benign 
on elastography. Histopathology proved it to be Nodular gynecomastia 
[Figure 9].
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